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Abstract Multiple sclerosis is the most frequent demyelin-
ating disease in adults. It is characterized by demyelination,
inXammation, gliosis and a variable loss of axons. Clinically
and histologically, it shares features with other demyelinating
and/or inXammatory CNS diseases. Diagnosis of an inXam-
matory demyelinating disease can be challenging, especially
in small biopsy specimens. Here, we summarize the histologi-
cal hallmarks and most important neuropathological diVeren-
tial diagnoses of early MS, and provide practical guidelines
for the diagnosis of inXammatory demyelinating diseases.
Keywords Multiple sclerosis · Demyelination · 
InXammation
Introduction
Multiple sclerosis (MS) is the most frequent demyelinating
disease in humans. Worldwide, it aVects approximately
1 million adults [7]. The annual costs are estimated to
amount up to D72,000 per year per patient depending on the
severity of the disease.
Due to the typical clinical symptoms, changes in CSF
and MRI Wndings in MS patients, biopsies are only rarely
required to establish the diagnosis. However, biopsies are
occasionally performed to exclude other treatable diseases
such as tumours, vasculitis or viral infections. The histolog-
ical characteristics of chronic MS lesions are well known to
neuropathologists, however diagnosing an inXammatory
demyelinating process in biopsy specimens may be chal-
lenging since the specimens are frequently small and often
represent only parts of a bigger lesion. Furthermore, the
histopathological hallmarks of acute MS diVer fundamen-
tally from the well-known characteristics of chronic
demyelinated plaques observed in autopsies. Here, we
describe the histopathological characteristics and most
important diVerential diagnoses of early MS lesions.
Histopathologically, the diVerential diagnoses of multiple
sclerosis includes other demyelinating diseases (Acute
disseminated encephalomyelitis (ADEM), HURST, vanish-
ing white matter disease, Alexander’s disease, X-linked
adrenoleukodystrophy (ALD) and central pontine myeli-
nolysis (CPM)), inXammatory diseases (vasculitis, viral
infections), sentinel lesions preceding lymphomas, tumours
(lymphomas, astrocytomas, oligodendrogliomas) and inf-
arcts. In the last 3 years, we received about 100 biopsies
from patients with MS. About 40 % of the MS lesions were
actively demyelinating lesions in which a further classiWca-
tion in diVerent histological patterns according to Lucchi-
netti, Lassmann and Brück [53] was possible. In our
experience the most frequent diVerential diagnoses include
vasculitis and encephalitis. Other disease entities, such as
Alexander’s disease, vanishing white matter disease and
PML are rare diseases and are even more rarely biopsied.
However, at our institution, we have seen single examples
of Alexander’s disease (n = 2), vanishing white matter
disease (n = 1), few examples of PML (n =2 ) ,  A L D
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(n = 1), measles encephalitis (n = 2), Rassmussen encepha-
litis (n = 1), sentinel lesions (n = 4) or ADEM/HURST
(n = 5) during the last 5 years. CPM and Marchiafavi-
Bignami are relatively rare diseases that most likely will
not be biopsied. We included them in our list of diVerential
diagnoses since they belong to the spectrum of demyelinat-
ing diseases and can be found occasionally in autopsies.
In this review, we discuss the diVerential diagnoses and
suggest practical guidelines for diagnosing inXammatory
demyelination in biopsy specimens.
Demyelinating diseases
Multiple sclerosis
The key features of early MS lesions are demyelination,
extensive macrophage invasion, perivascular and parenchy-
mal T cell inWltrates as well as relative axonal preservation.
Long-lasting chronic MS lesions (e.g. seen at autopsy) are
characterized by a relatively uniform appearance of exten-
sive primary demyelination (Fig. 1a) with variable axonal
loss, gliosis and minor inWltration by lymphocytes and
macrophages/microglia (Fig. 1b). Early MS lesions show a
profound inXammatory reaction consisting of T cells, a
variable but low number of B cells and massive inWltration
by foamy macrophages at the sites of demyelination
(Fig. 1c, d, e, f). A prominent reactive astrocytosis with for-
mation of so-called gemistocytes is another key feature of
early MS lesions. In addition, single dividing astrocytes
(so-called Creutzfeldt-Peters cells) can be observed. Ongo-
ing remyelinating areas as well as areas with active demye-
lination can often be seen next to each other [16]. In MS
lesions with areas of ongoing myelin destruction, three
diVerent patterns based on the myelin protein loss, extent of
oligodendrocyte preservation and composition of the
inXammatory inWltrates can be distinguished [53]. Patterns
I (Fig. 1c, d, e, f) and II share most of the histological char-
acteristics. Both patterns are characterized by a sharp bor-
der to the normal appearing white matter and an even loss
of all myelin proteins (MBP, CNP, PLP, MAG, MOG).
Areas of active demyelination (deWned by the presence of
myelin degradation products, such as MOG or CNP within
the cytoplasm of macrophages [18]; insert in Fig. 1d) are
inWltrated by T lymphocytes, some plasma cells and numer-
ous foamy macrophages. Macrophages represent the domi-
nant cell population in MS lesions and easily outnumber T
lymphocytes by a factor of 10 (Fig. 1d, e, f). The percent-
age of CD8-positive T cells varies by around 50–80 % of
the T cell population. In contrast to pattern I lesions, pattern
II lesions show deposition of activated complement
(C9neo) on degenerating myelin sheaths and in macro-
phages. Pattern III MS lesions are characterized by an ill-
deWned lesion border (Fig. 1g) and a preferential loss of
MAG, while other myelin proteins such as MBP, PLP or
MOG are still present or even appear to be overexpressed in
the lesion. Pattern III lesions demonstrate a marked oligo-
dendroglial loss; in areas of active myelin degradation, and
at the plaque border, oligodendrocytes with apoptotic mor-
phology can be observed (Fig. 1h). The inXammatory inWl-
trates consist of T cells, activated microglia/macrophages
and some plasma cells; complement deposits are not
observed in pattern III lesions. A fourth pattern character-
ized by demyelination due to dying oligodendrocytes in the
normal appearing white matter has been described in single
autopsy specimens of MS patients with a primary-progres-
sive disease course [53]. Since this pattern has been
observed only post mortem in single patients, we do not
describe it in more detail here.
A special variant of inXammatory demyelinating lesions
is seen in patients with Devic’s type of neuromyelitis
optica. NMO lesions (Fig. 1i, j) [54], which do not neces-
sarily have to be conWned to the spinal cord and optic
nerves, display necrotic changes in addition to primary
demyelination. These lesions are inWltrated by a signiWcant
number of eosinophils and neutrophils, in addition to T
cells and macrophages, and show prominent vascular Wbro-
sis and hyalinization. Typical features are a profound loss
of astrocytes (Fig. 1i) and in particular of the astrocytic pro-
tein aquaporin-4 [80]. Complement reactivity, which is
found predominantly on astrocytes of the glia limitans, is
seen in a rim or rosette-like pattern around vessels [54]
(Fig. 1j). In the serum of NMO patients, a speciWc antibody
reaction has recently been identiWed, which is directed
against the astrocytic water channel aquaporin-4 [50], and
which may help towards a Wnal diagnosis in such patients.
Acute disseminated encephalomyelitis and acute 
haemorrhagic necrotizing leukoencephalitis 
Acute disseminated encephalomyelitis (ADEM) and acute
haemorrhagic necrotizing leukoencephalitis (AHL or Hurst
syndrome) are monophasic diseases, which most com-
monly aVect children or young adults. The patients present
with multifocal neurological symptoms often associated
with a disturbed consciousness [35, 59, 78]. Recurrent dis-
ease courses have been suggested in single patients, making
a clinical diVerentiation between ADEM and MS diYcult
[22,  76]. The clinical outcome of ADEM is typically
favourable in contrast to its fulminant variant, Hurst syn-
drome. The pathophysiology of these diseases is unknown.
An autoimmune response to a CNS antigen triggered by
infection or vaccination has been discussed as the underlying
disease mechanism, since ADEM and Hurst syndrome are
often (but not always) associated with preceding infections
of the upper respiratory tract or vaccinations [41, 71].Acta Neuropathol (2008) 115:275–287 277
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Histologically, ADEM is characterized by small perivas-
cular demyelinating lesions (Fig. 2a), which may be conXu-
ent. The perivascular demyelinating “rim” is inWltrated by
numerous foamy macrophages and a few lymphocytes
(CD3- and CD8-positive T cells, B cells and plasma cells)
(Fig. 2b). In general, demyelination is—in contrast to MS
lesions—limited to perivascular areas with inXammatory
inWltrates. Thus, in brain biopsies profound inXammation in
the white matter, which is associated with perivascular
demyelination only, is suggestive of ADEM. Having said
Fig. 1 Chronic and early MS 
lesions. Chronic MS lesions 
have a sharp border with the 
surrounding normal appearing 
white matter [NAWM; LFB-
PAS staining; (a)]. Frequently, 
the demyelinated lesion centre is 
hypocellular while the lesion 
border and the normal appearing 
white matter show an increased 
number of macrophages and/or 
microglia (immunohistochemis-
try for the macrophage/
microglial marker KiM1P (b) 
and insert). Early MS lesions 
with pattern I are characterized 
by a sharp border with the 
NAWM [LFB-PAS staining; 
(c)]. The inXammatory inWltrates 
are dominated by foamy 
macrophages [immunohisto-
chemistry for KiM1P (d)], 
which may contain myelin 
degradation products in their 
cytoplasm (immunohistochem-
istry for the myelin protein MBP 
(insert in d)). T cells are 
diVusely distributed within the 
parenchyma of the lesion (e), but 
may also be found 
perivascularly in NAWM 
[immunohistochemistry for 
CD3; (f)]. Pattern III lesions 
show an ill-deWned lesion border 
[LFB-PAS staining; (g)]. In 
areas of active demyelination 
and NAWM, numerous dying 
oligodendrocytes (arrows) with 
condensed nuclei are observed 
[immunohistochemistry for 
CNP; (h)]. The insert in h shows 
a higher magniWcation of a CNP-
positive oligodendrocyte with a 
condensed nucleus. In NMO, a 
loss of astrocytes and glial Wbres 
[immunohistochemistry for 
GFAP; (i)] as well as a 
perivascular deposition of 
complement is observed 
[immunohistochemistry for 
C9neo; (j)]278 Acta Neuropathol (2008) 115:275–287
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this, however, it is nevertheless true that essentially similar
tissue alterations can be seen in the vicinity of active MS
lesions. It is therefore frequently not possible to deWnitely
distinguish between ADEM and MS, in particular when
only small biopsy specimens are available.
Hurst syndrome displays circular haemorrhages and
Wbrin deposits around smaller often necrotic vessels
together with inWltrates consisting of neutrophils, lympho-
cytes and macrophages. Among the inXammatory cells,
neutrophils are the dominant cell population. Similar to
ADEM, the loss of myelin is limited to the area of inXam-
mation. Frequently, the axon cylinders are severely aVected
resulting in necrotic foci rather than real demyelination [1,
34].
Fig. 2 DiVerent demyelinating 
diseases. ADEM is character-
ized by very limited perivascular 
demyelination [LFB-PAS; (a)] 
and perivascular inWltrates that 
consist mostly of foamy macro-
phages [immunohistochemistry 
for KiM1P; (b)]. In vanishing 
white matter, a diVuse loss of 
myelin is observed [LFB-PAS; 
(c)]. The number of oligoden-
drocytes in aVected white matter 
areas is markedly reduced 
[immunohistochemistry for CN-
Pase (d)]. In contrast to early MS 
lesions, the demyelinated lesions 
are inWltrated by relatively few 
macrophages [immunohisto-
chemistry for KiM1P; (e)]. In 
X-linked adrenoleukodystrophy, 
numerous bizarre astrocytes can 
be found within the lesions (ar-
rows in f) as well as lymphocytic 
perivascular inWltrates (arrow-
head in f; haematoxylin and 
eosin staining). The lesion areas 
are completely demyelinated (g) 
and in macrophages needle-like 
inclusions may be found (insert 
in g). In Alexander’s disease 
large CNS areas with an almost 
complete loss of myelin are 
found [immunohistochemistry 
for MBP; (h)]. The histopatholo-
gical characteristic of Alexan-
der’s disease is numerous 
GFAP-positive Rosenthal Wbres 
[immunohistochemistry for 
GFAP; (i)]Acta Neuropathol (2008) 115:275–287 279
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Central pontine myelinolysis
In 1959, Adams described for the Wrst time a disease char-
acterized by demyelinating symmetrically located central
pontine lesions and therefore named it central pontine mye-
linolysis [2]. Subsequent studies revealed that such demye-
linating lesions are not conWned to the pons, but can be
found in other regions of the brain that show a strong
admixture of grey and white matter such as cerebellum or
the extreme and external capsule [31, 64]. Central pontine
myelinolysis (CPM) is a rare disease associated with condi-
tions such as alcoholism, chronic malnutrition, cirrhotic
liver disease and transplantation. CPM has been related to a
rapid rise of serum sodium from a hyponatremic baseline
and similar demyelinating lesions have been found experi-
mentally such as electrolyte-induced myelinolysis in rats
[44, 45, 62].
Histopathologically, these lesions are characterized by
extensive, sharply demarcated demyelinating lesions. Oli-
godendrocytes are completely eliminated. The extent of
axonal damage varies between patients [30]; older lesions
may display cystic (necrotic) cavitations in the centre of the
demyelinating lesion [60]. Neurons are well preserved.
Within the lesions, numerous macrophages are observed.
The number of macrophages as well as the presence of
LFB-positive myelin degradation products within the cyto-
plasm of macrophages depends on the age of the lesion. In
contrast to MS lesions, lymphocytic inWltrates are rare. In
general, the diagnosis of CPM can be easily made due to
the typical distribution of the lesions. Even in rare instances
when extrapontine lesions are not accompanied by pontine
lesions [31, 64], the lack of lymphocytic inWltrates in CPM
lesions makes confusion with early MS unlikely.
A second demyelinating condition observed almost
exclusively in alcoholics is Marchiafava-Bignami (MFB)
disease. In MFB disease, lesions are mostly located in the
corpus callosum, but they may also be found in the optic
chiasm, anterior commissure and cortex [38]. The histopa-
thological characteristics are very similar to the changes
observed in CPM, indicating that these two conditions may
share some pathogenic mechanisms. However, MFB and
CPM are rarely observed in the same patient [29].
Vanishing white matter disease
Vanishing white matter (VWM) disease, also called
myelinopathia centralis diVusa or childhood ataxia with
diVuse central hypomyelination, has only recently been rec-
ognized as a disease entity caused by mutations in the
EIF2B1 gene family [49, 86]. In the majority of cases, the
disease begins neonatally or in early childhood after infec-
tions with fever or mild head injuries with an episodic or
progressive neurological deterioration. The neurological
symptoms include cerebellar ataxia, spasticity, optic atro-
phy and epilepsy. In addition to disease onset in childhood,
adult cases are also described [12,  27, 73]. MRI reveals
diVuse signal abnormalities and cystic changes in the cere-
bral white matter [73, 84, 85]. Due to its neurological char-
acteristics, early disease onset and extensive MRI
abnormalities, the disease would only rarely be considered
as a diVerential diagnosis to MS in children. However, in
adults the diagnosis of the disease may be diYcult. Histopa-
thologically, the disease is characterized by a widespread,
diVuse loss of myelin and oligodendrocytes (Fig. 2c, d),
accompanied by a signiWcant reduction in axons, character-
istics also found in MS lesions [17, 74, 88, 91]. In contrast
to early MS lesions, only a moderate inWltration with mac-
rophages/microglia is observed and T and B cells are absent
(Fig. 2e) [15]. Although only moderate numbers of macro-
phages/microglial cells are seen in VWM disease, single
macrophages containing myelin degradation products, such
as MAG, CNP, etc. within their cytoplasm may be present
in some VWM lesions, indicating an active ongoing demy-
elinating process. In the normal appearing white matter, the
number of oligodendrocytes is signiWcantly increased [15,
74]. A substantial number of oligodendrocytes display the
morphological characteristics of apoptosis and express
apoptosis-related proteins indicating that oligodendroglial
cell loss is an early feature in the disease process [15, 88].
Adrenoleukodystrophy
X-linked adrenoleukodystrophy is characterized by adrenal
insuYciency and CNS abnormalities. The disease is caused
by mutations in the ABCD1 gene leading to the accumula-
tion of very long chain fatty acids (VLCFA) [58]. In the
majority of patients, the disease starts in the Wrst or third/
fourth decade; only in a subset of patients is the brain
aVected (cerebral variant of ALD) [57]. Measurement of
VLCFA in plasma is the key diagnostic technique and
mutation analysis will conWrm the suspected diagnosis.
Biopsies are needed only in exceptional situations, e.g. in
patients in whom the diagnosis is unexpected due to an
atypical clinical course. Histologically, cerebral ALD
shares many features with MS lesions. Like MS lesions,
they are characterized by demyelination, relative loss of
axons and inXammation (Fig. 2f). Within the lesions, a
diVuse loss of myelin proteins (MBP, CNP, MOG, MAG,
PLP) is observed (Fig. 2g) and no sharp border between the
lesions and the “normal appearing” white matter can be
deWned, similar to pattern III MS lesions. The number of
oligodendrocytes is reduced within the lesion compared to
the NAWM, but we observed only a few oligodendrocytes
with an apoptotic or pycnotic morphology, similar to observa-
tions described by Ito et al. [36]. The number of axons
is reduced and axonal spheroids can be observed. The280 Acta Neuropathol (2008) 115:275–287
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perivascular and parenchymal inWltrates are composed of
CD3- and CD8-positive T cells, plasma cells as well as
macrophages, which may contain myelin degradation prod-
ucts within their cytoplasm. We did not see a deposition of
complement in macrophages or on myelin, but this has
been reported for a subset of patients in an earlier study
[72]. Reactive and bizarrely formed astrocytes are scattered
through the lesion (Fig. 2f). They are characterized by
large, plump cell bodies resembling large gemistocytes.
The detection of needle-like inclusions within macrophages
is typical for ALD (insert in Fig. 2g). These inclusions can
most readily be detected in the Luxol-Fast-Blue/PAS stain-
ing where they appear as small, colourless cavities.
Alexander’s disease
Alexander’s disease is caused by mutations in the GFAP
gene [51] and was Wrst described by WS Alexander [6] in
1949 and named after him in 1964 by Friede [25], who
described six additional cases. An infantile, juvenile and
adult variant can be distinguished. The infantile and juve-
nile type are often characterized by megalencephaly, hydro-
cephalus, seizures and developmental delay. Patients with
an adult onset may show symptoms similar to those of MS
patients [40]. MRI characteristics, such as extensive white
matter changes with frontal predominance, a periventricular
rim on T1, abnormalities in basal ganglia and brain stem
and contrast enhancement of particular grey and white mat-
ter structures allow the diagnosis of Alexander’s disease in
about 90% of patients [87]. The need for a biopsy is limited
to unusual disease courses or MRI characteristics such as
focal lesions, where the diagnosis of Alexander’s disease is
unexpected. Histologically, the most prominent feature in
patients with Alexander’s disease is the presence of numer-
ous Rosenthal Wbres, which often accumulate perivascu-
larly (Fig. 2i). Although Rosenthal Wbres can also be found
in MS lesions, they are conWned to old chronic lesions in
patients with long-standing disease [61,  77]. Due to the
extensive loss or pallor of myelin, the disease is regarded as
a leukodystrophy (Fig. 2h). In children with classical Alex-
ander’s disease, widespread destruction of myelin, some-
times to the extent of cavitation, can be observed. In
contrast, in adults only a patchy pallor of myelin may be
observed. Oligodendrocytes are absent or signiWcantly
reduced in the most severely aVected lesion areas and dying
oligodendrocytes with condensed or fragmented nuclei can
be observed. The axonal degeneration is mild compared to
the extensive loss of myelin. The demyelinated areas are
inWltrated by numerous foamy macrophages, while only
few lymphocytes are observed. T cells are mostly found
perivascularly and most of the T cells are CD8 positive.
In addition, a few B cells and plasma cells are seen in the
perivascular inWltrates.
Viral infections associated with demyelination
Progressive multifocal leukoencephalopathy 
Progressive multifocal leukoencephalopathy (PML) was
Wrst described in 1958 by Aström, Mancall and Richardson
[8]. PML is caused by an infection of oligodendrocytes by
the JC virus and it aVects patients who suVer from diseases
compromising the immune system, such as tuberculosis,
leukaemia and AIDS [23, 67, 93].
Histopathologically, PML is characterized by demyeli-
nated lesions of diVerent sizes, which may show necrotic
areas at the centre of the lesion [46]. The lesions are located
in all parts of the brain (hemisphere, brainstem, cerebel-
lum). The borders of the lesions may be ill deWned or
clearly deWned (Fig. 3a). The neuropathological hallmarks
are bizarre giant astrocytes (Fig. 3a) and oligodendrocytes
infected by JC virus showing enlarged hyperchromatic
nuclei (Fig. 3b). The demyelinated areas are inWltrated by
numerous foamy macrophages. Perivascular inWltrates con-
sisting of T cells, macrophages and a few B cells may be
observed, especially in AIDS-associated PML [46]. JC
virus infection as the cause of demyelination can be proven
by the detection of JC virus in oligodendrocytes and (more
rarely) astrocytes; infected cells are more frequently found
at the lesion border than in the demyelinated lesion centre.
Subacute sclerosing panencephalitis
Subacute sclerosing panencephalitis (SSPE) is caused by a
persistent measles virus infection. The onset of the disease,
that aVects mostly children, is insidious, and the outcome
often fatal. With the introduction of measles vaccination,
the incidence of SSPE has signiWcantly decreased.
First, pathologic changes are observed in the white mat-
ter of the hemisphere [63]. The histopathological changes
are relatively unspeciWc: widespread, but focal perivascular
inWltrates in the white and grey matter associated with
astrocytic proliferation as well as microglial nodules. These
inXammatory reactions are accompanied by diVuse demye-
lination (Fig. 3c), which can be very limited in early dis-
ease stages. In neuronal or oligodendroglial nuclei, speciWc
inclusions may be found, the so-called Cowdry type A
inclusion bodies. The detection of measles virus antigen by
immunohistochemistry leads to the deWnitive diagnosis of
SSPE (Fig. 3d, e) [20].
Encephalitis without demyelination
Encephalitis may present with multifocal lesions in the
grey and white matter and is therefore the basis for a possi-
ble diagnosis of multiple sclerosis in certain circum-
stances. Encephalitis without demyelination is mostActa Neuropathol (2008) 115:275–287 281
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frequently caused by infectious pathogens or an autoim-
mune process.
Among the infectious pathogens, viral infections are the
most important cause of encephalitis without demyelina-
tion. Necrotizing viral encephalitis, such as herpes, CMV
or VZV, is easy to diagnose; the detection of the virus
by immunohistochemistry permits the deWnitive diagnosis.
Unfortunately, there are numerous additional viruses,
which may cause encephalitis, but are more diYcult to
identify. Arboviruses (West Nile virus, Japanese encephali-
tis, St Louis encephalitis, Western and Eastern equine
encephalitis, Central European tick-born encephalitis) and
enteroviruses (echovirus, coxsackievirus) are some known
examples that infect the CNS and result in encephalitis and/
or meningitis. Viral encephalitis aVects predominately the
cortex. The histological characteristics consist of perivascu-
lar and parenchymal inWltrates (lymphocytes, macrophages,
microglia; Fig. 3g), microglial nodules as well as dying
nerve cells surrounded by microglial cells (neuronophagia;
Fig. 3f). Neurons and granzyme B expressing CD8-positive
T can be found in close proximity, suggesting a direct cyto-
toxic eVect of CD8 T cells on neurons.
Autoimmune processes are a further cause for encephalitis
without demyelination. In a subset of patients, autoimmune-
mediated encephalitis is associated with malignancies
(also called paraneoplastic encephalopathy or paraneo-
plastic encephalitis). Limbic encephalitis is the most
frequent autoimmune encephalitis with 120 cases described
in the literature (for review see [89]. Clinically, it is charac-
terized by short-term memory impairment, temporal lobe
seizures and psychiatric symptoms. The typical MRI
Wndings consist of signal abnormalities in the mesial
temporal lobes without contrast enhancement [10, 89].
In CSF and/or serum, autoantibodies to neuronal antigens
(e.g. Voltage-gated potassium channels or intraneuronal
antigens (such as anti-Hu, anti-Ma2)) [10] can be detected
Fig. 3 PML, SSPE and viral 
encephalitis. PML lesions may 
be characterized by a sharp 
lesion border [LFB-PAS; (a)]. 
The histopathological hallmarks 
are bizarre astrocytes (immuno-
histochemistry for GFAP; insert 
in a) and viral inclusion bodies 
in oligodendrocytes and astro-
cytes [immunohistochemistry 
with antibodies recognizing JC 
antigens; (b)]. SSPE is charac-
terized by demyelinated lesions 
often accompanied by extensive 
axonal loss [immunohisto-
chemistry for MAG; (c)]. In 
oligodendroglial nuclei, viral 
inclusions can be found, which 
are intensively eosinophilic 
[haematoxylin and eosin; (d)]. 
Measles virus antigen can be 
identiWed by immunohistochem-
istry (e). In acute viral encepha-
litis, e.g. in acute measles 
encephalitis, marked perivascu-
lar inWltrates are observed while 
the myelin is not aVected 
[LFB-PAS staining; (f)]. In this 
patient, measles virus antigen 
could be detected in oligoden-
droglial nuclei (insert in f). The 
perivascular inWltrates may be 
dominated by B cells [immuno-
histochemistry for the B cell 
marker CD20; (g)]282 Acta Neuropathol (2008) 115:275–287
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in the majority of patients. However, the pathogenesis of
autoimmune encephalitis is still a matter of debate; auto-
antibody-mediated neuronal cell lysis as well as cellular
immune mechanisms are discussed [3, 4, 70]. The histolog-
ical CNS changes in patients with autoimmune encephalitis
consist of perivascular T and B cell inWltrates, microglial
activation, microglial nodules and gliosis [19, 90]. Rasmus-
sen encephalitis is another rare syndrome in which an auto-
immune reaction is the suspected underlying cause of the
disease. It aVects predominately children, but it can in rare
instances also be seen in adults. It is characterized by a pro-
gressive destruction of one hemisphere. In early disease
phases, the pathological changes consisting of focal and/or
perivascular inXammatory inWltrates (with a prominent
number of CD8 positive T cells), microglia activation,
astrocytosis and single neuronophagia are limited to the
superWcial and deep cortical layers. Cytotoxic T cells are
seen in close association with cortical neurons, suggesting a
T cell-mediated mechanism of tissue injury [13]. In addi-
tion, profound loss and acute destruction of astrocytes is a
characteristic feature of active lesions. In contrast, in late
disease phases, extensive destruction with vacuolation of
all cortical layers, massive loss of neurons and a prominent
astrocytosis were found, while the lymphocytic inWltration
was minimal or absent [13]. The subcortical white matter
may be aVected as well, displaying a diVuse pallor of mye-
lin, loss of axons, foci of lymphocytic inWltrates and reac-
tive astrocytic changes [11, 69].
Vasculitis
CNS vasculitis is a heterogeneous disease group, which
represents either isolated vasculitis of the CNS or is part of
a systemic vasculitis, such as Wegner’s granulomatosis,
Churg-Strauss syndrome, polyarteritis nodosa or collage-
noses associated with vasculitis (for review, see [37, 92].
CNS vasculitis mostly aVects small- and medium-sized
vessels. The histological hallmarks of CNS vasculitis are
inWltration of the vessel wall with inXammatory cells
(Fig. 4a) and a Wbrinoid necrosis of the vessel wall. The
inXammatory destruction of the vessels (Fig. 4b) results in
thrombosis of the vessels causing strokes or haemorrhages.
The inXammation within the vessel wall consists of macro-
phages, T cells and B cells, and occasionally giant cells are
Fig. 4 In vasculitis, the inWltrates are localized within the vessel wall
and consist mostly of T cells [immunohistochemistry for the T cell
marker CD3; (a)]. Frequently, the vessel wall is destroyed [reticulin
staining; (b)]. Noncaseating granulomas consisting of multinucleated
giant cells and epitheloid cells surrounded by a lymphocytic wall are
the histological hallmarks of neurosarcoidosis (c). In CNS lymphomas,
a perivascular accumulation of neoplastic B cells is characteristic
[haematoxylin and eosin; (d)]. The high proliferation index in lympho-
mas may help to distinguish lymphomas from vasculitis or viral
encephalitis. However, occasionally also cases of vasculitis and
encephalitis show a marked proliferation. The detection of a monoclo-
nal B cell population by PCR conWrms the suspected diagnosis of a B
cell lymphoma [immunohistochemistry for the proliferation marker
Ki67; (e)]Acta Neuropathol (2008) 115:275–287 283
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found as well. The vasculitis may be accompanied by mild
to severe inXammatory inWltrates in the CNS parenchyma
making the diVerentiation between MS and vasculitis occa-
sionally diYcult in the absence of a Wbrinoid necrosis of the
vessel walls or thrombotic vessels. In contrast to MS, no
demyelination is observed.
Sarcoidosis
Sarcoidosis is a chronic relapsing inXammatory disease of
unknown aetiology with variable clinical manifestations;
the most common presentation of sarcoidosis is pulmonary
involvement. The CNS is aVected in 5–25 % of the patients
[39, 55, 81]. Cranial MRI reveals the predilection of neuro-
sarcoidosis for the leptomeninges and basal midline struc-
tures such as hypothalamus, optic chiasm and the pituitary
gland, but also multiple hyperintense parenchymal and
periventricular lesions are observed, which may be indistin-
guishable from MS lesions [56, 65, 83]. In the absence of a
systemic disease, pathological evaluation of one of the
CNS lesions is the only way to establish the diagnosis of
neurosarcoidosis.
Histopathologically, neurosarcoidosis is characterized
by non-caseating granulomas consisting of epitheloid his-
tiocytes, lymphocytes, plasma cells and multinucleated
giant cells (Fig. 4c). The nuclei in the giant cells are either
arranged along the cell border or are randomly clustered in
the cytoplasm. In rare instances, necrotizing granulomas
can be found in patients with neurosarcoidosis [65]. Ziehl-
Neelsen and auramine-rhodamine stainings (mycobactria),
silver impregnation techniques (fungi) and examination
with polarized light help to distinguish neurosarcoidosis
from other granulomatous diseases such as tuberculosis,
fungal infections (e.g. histoplasmosis, aspergillosis, crypto-
coccosis) or foreign body type granulomatous inXammation.
Hypoxic-ischaemic demyelination and necrosis
Multifocal ischaemic lesions may mimic the radiological
Wndings of MS, especially in the early stages [68]. Histopa-
thologically, hypoxia or ischaemia results in necrosis rather
than demyelination. In contrast to demyelination, necrotic
processes are characterized by loss of axons and myelin.
Stainings, which identify myelin and axons will help to dis-
tinguish between necrotic and demyelinating diseases.
Early stages of strokes, which show a diVuse myelin pallor
and preserved axons also display marked neuronal cell
death in the aVected cortex areas and/or an invasion of
granulocytes; neither Wnding is observed in MS lesions.
Binswanger’s disease is characterized by diVuse perivascu-
lar demyelination. The atherosclerotic vessel changes and
the absence of a marked inXammatory reaction lead to the
unequivocal diagnosis of Binswanger’s disease.
Tumours
Sentinel lesions
Malignant lymphoma, which accounts for less than 1 % of
all brain tumours, may be associated with or even preceded
by demyelinating lesions. The underlying mechanism for
developing sentinel lesions is unknown. A viral pathogene-
sis, malignant transformation of a chronic inXammatory
process or demyelination due to anti-myelin antibodies
secreted by the lymphoma cells are discussed [32]. The
sentinel lesions show typical histological features of MS
lesions, such as demyelination, extensive macrophage inWl-
tration, lymphocytic inWltrates consisting of T cells (CD3
and CD8), B cells and plasma cells and a relative preserva-
tion of axons. These lesions are indistinguishable from MS
lesions by histology [5, 14, 47, 48]. The diagnosis of senti-
nel lesions should be considered if patients with untypical
age of onset of MS (>60 years) present with monofocal
demyelinating lesions. MR spectroscopy may help to dis-
tinguish between demyelinating disease and lymphoma
[47]. For pathology, complete serial sections of the respec-
tive biopsy may help to arrive at a deWnite diagnosis, since
in such cases small perivascular angiocentric accumula-
tions of neoplastic T or B cells can be found.
Lymphoma
Primary B cell lymphomas of the CNS (PCNSL) are rela-
tively rare; they account for less than 1% of CNS tumours.
Although lymphomas and MS lesions may cause similar
MRI changes [52,  66], these two entities can be distin-
guished easily by histology. B cell lymphomas are easy to
diagnose due to their high cellularity, angiocentric growth
pattern (Fig. 4d), typical morphology, high proliferation
(Fig. 4e), and immunopositivity for B cell markers. How-
ever, treatment of patients with steroids prior to biopsy may
obscure the diagnosis of lymphoma. Treatment with ste-
roids may lead to the almost complete elimination of the
neoplastic B cell population resulting in astrogliosis and
perivascular T cell inWltrates resembling vasculitis or
encephalitic diseases [28]. Occasionally, B cell lymphomas
are preceded by demyelinating lesions, undistinguishable
from MS lesions, as described in detail above [5, 14, 47,
48].
A rare variant of PCNSL is the lymphomatosis cerebri
that in contrast to the typical PCNSL does not form a cohe-
sive mass, but inWltrates into the CNS diVusely and widely
[9, 75]. The patients typically present with rapidly progres-
sive dementia. As a result of the diVuse inWltration of lym-
phomatosis cerebri, MRI Wndings may mimic other white
matter disorders, such as Binswanger disease, leukoenceph-
alopathy, viral infection or inWltrating glioma [21, 26, 82].284 Acta Neuropathol (2008) 115:275–287
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Histopathologically, lymphomatosis cerebri is character-
ized by the inWltration of the white matter with individual
CD20-positive lymphoid lymphoma cells without forming
mass lesions [9, 42, 75]. Modest numbers of lymphoma
cells together with reactive T cells can be found perivascu-
larly. These histopathological changes may be associated
with subtle myelin pallor. One case report describes the
presence of focal necrosis [9].
It may be especially challenging to diVerentiate T cell
lymphomas of the CNS from inXammatory entities, such as
vasculitis. In a large series of PCNSL (n = 370), T cell ori-
gin has been described in 2% of the cases [24]. Primary T
cell lymphomas of the CNS frequently show an angiocen-
tric growth pattern. The morphology of the neoplastic T
cells has been described as small, medium to large or pleo-
morphic [33, 79]. Parenchymal necroses as well as necrotic
vessels may be present. Immunohistochemically, the neo-
plastic cells express CD3 as well as CD8 and perforin or
granzyme B [33]. Proliferation is usually prominent. The
detection of a clonal T cell receptor gene rearrangement by
PCR helps to establish the diagnosis of a T cell lymphoma
[33].
Other CNS tumours
Since early MS lesions are characterized by hypercellular-
ity as well as extensive and prominent astrocytosis, they
might be confused with astrocytic tumours, especially in
small biopsy specimens. Furthermore, reactive astrocytes in
MS lesions often display a marked pleomorphism and even
astrocytes, with atypical mitotic Wgures (Creutzfeldt-Peters
cells) being observed in MS lesions. Therefore, low-grade
astrocytomas, especially those with a prominent gemistocy-
tic component may lead to confusion in the diVerential
diagnosis of demyelinating lesions.
The hypercellularity observed in early MS lesions is at
least partly caused by macrophages. Cytologically, macro-
phages may resemble neoplastic oligodendrocytes. How-
ever, while neoplastic oligodendrocytes often have a clear
cytoplasm as an artiWcial reaction to the embedding pro-
cess, macrophages display a foamy and granular cytoplasm.
The presence of demyelination and relative axonal preser-
vation together with stainings identifying macrophages
(e.g. CD68, KiM1P) will help to avoid misdiagnosis.
Review of the clinical and radiological Wndings will further
help towards a correct diagnosis.
Practical guidelines for diagnosing MS
We recommend starting the diagnostic process with three
basic stainings: HE, LFB-PAS myelin staining and a stain-
ing for the detection of axons (e.g. Bielschowsky’s silver
impregnation). These three stainings are suYcient to deter-
mine the extent of inXammation, the localization of inXam-
matory inWltrates (perivascular versus diVuse in the
parenchyma), the extent of demyelination (LFB-PAS) and
the severity of axonal damage. Additional immunohistolog-
ical stainings for macrophages, T cells, B cells, plasma
cells, astrocytes and proliferation are suYcient to narrow
down the diVerential diagnosis as described in Fig. 5. Hav-
ing an additional myelin marker at hand might be helpful,
especially because immunohistochemistry for myelin
proteins is less time consuming than conventional myelin
stainings, such as LFB. We recommend as immunohisto-
chemical myelin markers anti-MBP or anti-CNP, which
both reliably label myelin sheaths and, in the case of the
latter one, also oligodendrocytes.
An important Wrst step in the diagnostic process is to
exclude a neoplasm. Stainings for myelin, axons and mac-
rophages will help in distinguishing between MS and a glial
tumour. Limited demyelination together with dense (peri-)
vascular accumulation of T and/or B cells characterizes
lymphomas and vascultits. Additional immunohistochemi-
cal stainings for identiWcation of B cells (CD20, CD79a)
and proliferation (Ki67) make it possible to diVerentiate
between lymphoma and MS. The detection of a monoclonal
B cell population by PCR leads to the unequivocal diagno-
sis of a B cell lymphoma of the CNS. Extensive demyelina-
tion is found in MS, sentinel lesions, PML and rare
demyelinating diseases such as Alexander’s disease or leu-
kodystrophies. Alexander’s disease and leukodystrophies
can be easily distinguished from multiple sclerosis lesions
by the presence of numerous Rosenthal Wbres in the former
and phagocytic inclusions in the latter. PML is character-
ized by bizarre astrocytes, and the suspected diagnosis can
be proved if JC virus is detected within the oligodendro-
cytes and/or astrocytes. Other demyelinating diseases such
as CPM and vanishing white matter show a very limited
number of T and B cells in contrast to MS lesions. By com-
bining a myelin staining with an axonal staining, a demye-
linating process can be distinguished from a necrotic one.
Necrosis is a very rare Wnding in MS lesions; except for ful-
minant MS disease courses, it is rarely observed in MS.
When present, a diVerential diagnosis of NMO should be
considered. The presence of necrosis strongly favours the
diagnosis of either a necrotic encephalitis or an ischaemic
lesion.
Once the diagnosis of an inXammatory demyelinating
process is established, further stainings for diVerent myelin
proteins, apoptotic cells and the composition of the inXam-
matory reaction makes it possible to further distinguish one
of the diVerent MS patterns as described above [53]. This
subclassiWcation can only be performed in actively demye-
linating lesions characterized by the presence of myelin
degradation products, such as MOG, MAG or CNP within
the cytoplasm of macrophages. Since the histological MSActa Neuropathol (2008) 115:275–287 285
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pattern may inXuence the treatment strategies [43], we rec-
ommend sending the MS biopsies to specialized centres for
further classiWcation.
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